USA - NASDAQ:BFRI - US09077D2099 - Common Stock
ChartMill assigns a Buy % Consensus number of 83% to BFRI. The Buy consensus is the weighted average rating of the current analysts ratings.
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-05-19 | Benchmark | Maintains | Buy -> Buy |
| 2024-11-15 | Benchmark | Reiterate | Buy -> Buy |
| 2024-08-16 | Benchmark | Reiterate | Buy -> Buy |
| 2023-08-31 | Benchmark | Reiterate | Buy -> Buy |
| 2023-07-05 | Benchmark | Maintains | Buy -> Buy |
| 2023-05-15 | Benchmark | Reiterate | Buy -> Buy |
| 2023-03-09 | Benchmark | Reiterate | Buy |
| 2023-01-31 | Benchmark | Reiterate | Buy |
| 2021-12-15 | Benchmark | Initiate | Buy |
| 2021-11-24 | Roth Capital | Initiate | Buy |
8 analysts have analysed BFRI and the average price target is 6.63 USD. This implies a price increase of 502.73% is expected in the next year compared to the current price of 1.1.
The consensus rating for BIOFRONTERA INC (BFRI) is 82.5 / 100 . This indicates that analysts generally have a positive outlook on the stock.